Preclinical evidence of PDE4 targeting in a rat model of allergic asthma indicated that ovalbumin sensitization and challenge significantly increased the activity of PDE4 and mRNA expression of different PDE4 isoforms, including PDE4A, PDE4C and PDE4D [127]. This evidence concerns the gene PDE4A and allergic asthma.